Percutaneous Nephroscopic Surgery: Using Tranexamic Acid To Prevent Intraoperative Bleeding

At the present stage Percutaneous nephrolithotomy is the most rational method to treat large high-density stones that resist distant lithotripsy, multiple stones in pyelocaliceal system and staghorn calculus of complex configuration. The accumulation of experience in this field and the improvement of technology implementation in operating endoscopic interventions led to the expansion of indications for percutaneous nephrolithotomy and reduced the number of intra-and postoperative complications. One option to prevent bleeding complications during surgery is the use of tranexamic acid in the preoperative period. Comparative clinical analysis of two groups of patients who underwent percutaneous nephrolithotomy showed that the results of surgical treatment of patients with nephrolithiasis after administering tranexamic acid are different from patients that did not receive this drug. Thus, the use of tranexamic acid has a perspective in percutaneous nephrolithotomy as a drug that greatly reduces the risk of intraoperative bleeding and the need for blood transfusions.